Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
A PHASE2/PHASE3 clinical study on Binge-Eating Disorder and Obesity, this trial is completed. The trial is conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and has accumulated 14 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2023 — Mar 2024 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2022 — Jun 2023 [monthly]
Active Not Recruiting PHASE2_PHASE3
▶ Show 9 earlier versions
-
Mar 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Enrolling By Invitation → Active Not Recruiting
-
Sep 2021 — Mar 2022 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Jun 2019 — Jul 2020 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Jul 2018 — Jun 2019 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Sep 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Feb 2017 — Sep 2017 [monthly]
Enrolling By Invitation PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .